Feasibility of serodiagnosis of ovarian cancer by mass spectrometry.
West-Nørager M, Bro R, Marini F, Høgdall EV, Høgdall CK, Nedergaard L, Heegaard NH
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient age, frozen storage duration, and diagnosis of malignant versus benign ovarian tumor on the MALDI-TOF MS peak patterns in serum. Serum was stored at -80 degrees C within 6 h of blood collection.
Summary of Findings
The authors report no patient-age dependent correlations in MALDI-TOF MS data. Duration of serum storage up to 15 months could be predicted with some degree of confidence based on peak patterns, but there was more uncertainty beyond 15 months. The authors were able to develop a model to differentiate serum MALDI-TOF MS peak patterns from patients with benign versus malignant ovarian tumors, but it did not perform as well as existing serum markers.
Biospecimens
FluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NeoplasticBenignNeoplasticCarcinomaPlatforms
ProteinMALDI-TOF MSPeptideMALDI-TOF MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition BenignOvarian cancerPreaquisition Patient age Mean 45 yearsMean 65 yearsStorage Storage duration 1-23 months